AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, shares the latest post-Thanksgiving «tripledemic» trends, as well as findings from a new CDC study on how the updated boosters performed in the real world. American Medical Association CXO Todd Unger hosts.
Read More
AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the spike in flu, respiratory syncytial virus (RSV), and COVID cases across the country. American Medical Association CXO Todd Unger hosts.
Read MoreAMA Director of Science, Medicine and Public Health Andrea Garcia, JD, MPH, walks through the updated CDC COVID-19 Guidance, including what’s changed, what hasn’t, and what it means for kids headed back to school during National Immunization Awareness Month this August.
#ivax2Protect
Plus, FDA has authorized a plan for using a partial dose of the Jynneos monkeypox vaccine via intradermal injection to extend supply. This also allows use of Jynneos to prevent monkeypox in kids under 18. American Medical Association CXO Todd Unger hosts.
Visit AMA’s monkeypox resource center here: https://www.ama-assn.org/delivering-care/public-health/monkeypox-resource-center
Read MoreThe latest on Omicron subvariants, delays in state-by-state COVID case reporting and more with AMA Director of Science, Medicine and Public Health, Andrea Garcia JD, MPH. American Medical Association CXO, Todd Unger hosts.
Read MoreAMA CXO Todd Unger chats with AMA’s immediate past president, Susan Bailey, MD, about big takeaways from her recent conversation with Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research at the FDA. Their talk covered COVID-19 second dose boosters and pediatric vaccines.
Read MoreAMA CXO Todd Unger discusses the latest Johnson & Johnson COVID vaccine news with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering a newly released estimate for COVID-19 related deaths using excess mortality, as well as summer spikes of coronavirus cases, hospitalizations, and that masking up in airports or high-risk settings continues to reduce chances of COVID infection.
Read MoreAMA CXO Todd Unger reviews COVID-19 case numbers and the legal battle over mask mandates with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the CDC’s latest health alert for COVID therapies, as well as the FDA’s approval of Remdesivir to treat pediatric coronavirus patients (kids 12 and younger).
More information on the CDC’s health alert: https://emergency.cdc.gov/han/2022/han00463.asp
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering updates from FDA’s vaccine advisory committee meeting regarding a revised version of the COVID vaccine for fall, the FDA suspending use of a monoclonal antibody drug by GlaxoSmithKline known as sotrovimab to treat high-risk COVID-19 patients in the U.S. because it’s unlikely to be effective against BA.2, and a clinical trial published in NEJM confirms that the anti-parasitic drug, ivermectin, showed no sign of alleviating COVID.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the spread of the BA2 variant, Medicare paying for at-home COVID tests, as well as the latest from the FDA and CDC regarding who may get a second COVID booster shot.
Read MoreAMA CXO Todd Unger reviews COVID-19 trending topics and news related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the FDA’s authorization of a second booster shot, as well as changes in COVID treatments and therapies. Additionally, uninsured patients may have to pay high prices out-of-pocket for COVID tests and vaccinations due to lack of federal funding and stalled budget approval.
Read More